Thursday, 12 July 2012

FTC requests more information on Watson-Actavis deal



(Reuters) - Watson Pharmaceuticals Inc said the Federal Trade Commission requested additional information regarding Watson's proposed acquisition of Swiss generic drug firm Actavis Group.





via Reuters: Health News Read More Here..

No comments:

Post a Comment